Management of Pediatric Afebrile Seizures

Diagnostic Approach

For children ≥6 months with afebrile generalized seizures who return to neurologic baseline, advanced imaging may be deferred to outpatient settings, and routine anticonvulsant prophylaxis is not recommended, as suggested by the American Academy of Pediatrics 1, 2
The American Academy of Pediatrics recommends assessing for return to neurologic baseline, which is the critical decision point for imaging and disposition 1, 2

Emergent neuroimaging is not recommended for first unprovoked afebrile seizures in well-appearing children who return to baseline, according to the American Academy of Pediatrics 1
Defer imaging to outpatient settings when the child is ≥6 months old, has no high-risk historical features, has a normal neurologic examination, returns to neurologic baseline, and is not a patient with preexisting epilepsy experiencing typical seizure semiology, as recommended by the American Academy of Pediatrics 1, 2
The American Academy of Pediatrics suggests a low threshold for emergent neuroimaging when there is status epilepticus presentation, failure to return to neurologic baseline, neurologic deficits on examination, or predisposing conditions 1, 2, 3

For seizures lasting >5 minutes, administer lorazepam 0.05-0.1 mg/kg IV (maximum 4 mg) given slowly at 2 mg/min as first-line treatment, as recommended by the American Academy of Pediatrics 2

Admit children who have not returned to neurologic baseline, have concerning neurologic findings, or require ongoing seizure management, according to the American Academy of Pediatrics 1, 2, 3

Prophylactic anticonvulsant therapy is not recommended after a first afebrile seizure, as stated by the American Academy of Pediatrics 2, 3
If epilepsy is diagnosed after appropriate evaluation, monotherapy is the preferred initial approach using medications such as oxcarbazepine, topiramate, or levetiracetam, as suggested by the American Academy of Pediatrics 2

The risk of developing epilepsy after an afebrile seizure varies based on individual risk factors, and there is no evidence that prophylactic treatment prevents the development of epilepsy, according to the American Academy of Pediatrics 2, 4